HCA Healthcare is preparing investors for a largely flat earnings performance in 2027 as resilient patient demand collides with weaker reimbursement economics. CEO Sam Hazen expects full-year 2027 earnings to be generally consistent with 2026 levels, with detailed guidance scheduled for release in January following the October 27 earnings call. The company anticipates patient volume growth of 2% to 3% next year, but profitability is being weighed down by a deteriorating payer mix. Specifically, the shift from exchange coverage to uninsured care reduced pretax income by approximately $400 million in the third quarter, as uninsured patients now represent 10.5% of equivalent admissions compared to 8.5% a year earlier. Management also forecasts lower Medicaid supplemental payments, estimating a reduction of $550 million to $650 million for next year due to grandfathered state program approvals expiring. While management expects fewer people to lose exchange coverage in the coming year than in 2026, the transition of these patients into uninsured status at a near one-for-one rate continues to impact the economics of admissions. To offset pressure from reimbursement changes and payer mix shifts, HCA is relying on cost discipline, network initiatives, and its resiliency program. CFO Mike Marks noted that the company has good visibility into its plans for 2027 and beyond, emphasizing that a return to long-term growth depends on moving beyond the most severe exchange-related payer shift and generating significant value from strategic initiatives.